Robert Bayer Explained

Robert Bayer is a US researcher of lobster nutrition, management, and pathology.

Career

Since 2018, he is serving as the chief science officer at Lobster Unlimited, a company that is creating value-added products from lobster processing waste byproducts.^{[1] [2]} From 1995 to 2018, he served as the executive director of The Lobster Institute at the University of Maine,^[3]

Bayer is an alumnus of the University of Vermont, where he received his bachelor's and master's degree, and Michigan State University, where he received his doctoral degree.^[4] He is also a professor emeritus of Animal and Veterinary Sciences at the University of Maine. He holds several research patents, including one for gaffkemia vaccine^[5] and another one for the application of lobster hemolymph to treat mammalian tissue lesions.^[6]

Notes and References

1. Web site: Robert Bayer - School of Food and Agriculture - University of Maine. 2021-02-08. School of Food and Agriculture. en-US.
2. Web site: Lobster Unlimited. 2021-02-08. scratchpad. en.
3. Web site: Treating warts with a lobster's blood? This Maine researcher is out to prove it can be done. Daniels. Jeff. CNBC. February 20, 2017. February 9, 2021.
4. Web site: Robert C. Bayer – Maine Science Festival. 2021-02-08. en-US.
5. US. 4215108. Lobster gaffkemia vaccine. 1980-07-29. Research Corp.. Rittenburg. James H.. Bayer. Robert C..
6. Lobster hemolymph as a utility for treatment of mammalian tissue lesions. 2013-02-16. US. 9078906. Bayer. Robert C..